Trial ID or NCT#

NCT03090607

Status

RECRUITING

Purpose

This is a prospective, multi-center, double-blind randomized controlled trial designed to demonstrate the safety and efficacy of Aluvra for the treatment of GERD.

Official Title

A 12-month Double-blind, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Efficacy of Endoluminal Aluvra™ for the Treatment of Gastroesophageal Reflux Disease

Eligibility Criteria

Ages Eligible for Study: Older than 22 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

John Clarke, MD
Gastroenterologist, Motility specialist
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
Kirsten Regalia, MD
Gastroenterologist
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology

Contact us to find out if this trial is right for you.

CONTACT

SPECTRUM